Last update 14 Feb 2026

LMP2 Antigen-specific TCR T cells(Sun Yat-sen University)

Overview

Basic Info

Drug Type
TCR-T Cell therapy
Synonyms-
Target
LMP2
Action
modulators
Mechanism
LMP2 modulators(Latent membrane protein 2 modulators), Gene transference(Gene transference), T lymphocyte replacements
Therapeutic Areas
NeoplasmsMouth and Tooth DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication-
Inactive Indication
Head and neck cancer metastaticNasopharyngeal Cancer, RecurrentNasopharyngeal Carcinoma
Originator Organization
Sun Yat-Sen UniversitySun Yat-Sen University
Active Organization-
Inactive Organization
Sun Yat-Sen UniversitySun Yat-Sen University
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LMP2 Antigen-specific TCR T cells(Sun Yat-sen University)
NCT03925896
/ Unknown statusPhase 1IIT
LMP2 Antigen-specific High-affinity T Cell Receptor (TCR)-Transduced Autologous T-cell Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma, an Open-label, Single-center, Phase I Clinical Trial
100 Clinical Results associated with LMP2 Antigen-specific TCR T cells(Sun Yat-sen University)
Login to view more data
100 Translational Medicine associated with LMP2 Antigen-specific TCR T cells(Sun Yat-sen University)
Login to view more data
100 Patents (Medical) associated with LMP2 Antigen-specific TCR T cells(Sun Yat-sen University)
Login to view more data
100 Deals associated with LMP2 Antigen-specific TCR T cells(Sun Yat-sen University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Head and neck cancer metastaticPhase 1
China
Sun Yat-Sen UniversitySun Yat-Sen University
07 Aug 2019
Nasopharyngeal Cancer, RecurrentPhase 1
China
Sun Yat-Sen UniversitySun Yat-Sen University
07 Aug 2019
Nasopharyngeal CarcinomaPhase 1
China
Sun Yat-Sen UniversitySun Yat-Sen University
07 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free